Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05778357
Other study ID # GErol
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 25, 2022
Est. completion date October 25, 2022

Study information

Verified date March 2023
Source Istanbul University - Cerrahpasa (IUC)
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Development; It covers the areas of physical, mental, emotional and social development. Development in one area affects other areas as well. Infancy is the period in which children grow and develop the fastest. Babies need many environmental factors and stimulants in order to have a healthy developmental process. For the Covid 19 pandemic, many restrictions have been made in Turkey to reduce the spread of the epidemic and to maintain social distance between people. It has been suggested that individuals practice their own social isolation. It has also caused babies who spend their time at home during the pandemic process to be deprived of environmental stimuli. In current studies in the literature, it has been reported that the COVID-19 pandemic affects infant and child development significantly and negatively. It has been reported that the risk of delay in children who have experienced the COVID-19 pandemic is especially in the fine motor and communication areas. There is a limited number of studies in the literature on this subject. No study was found in Turkey. The aim of this study is to evaluate the neuromotor development of infants in early childhood (6-24 months) in the Covid-19 pandemic and to reveal the effects of the pandemic process. Denver II Developmental Screening Test was used to evaluate the neuromotor development of healthy infants aged 6-24 months, who applied to the healthy pediatric outpatient clinic of Acıbadem Altunizade Hospital, and Alberta Infant Motor Scale was used to evaluate gross motor functions.


Description:

It is an observational study. Purpose of the study: evaluating the neuromotor development of infants in early childhood (6-24 months) in the Covid-19 pandemic and revealing the effects of the pandemic process. 75 healthy infants aged 6-24 months were included. - Will there be developmental delays in children born in the Covid 19 pandemic? - In which parameter delay is observed the most. Denver II Developmental Screenin Test and Alberta Infant Motor Scale were applied to the participants.


Recruitment information / eligibility

Status Completed
Enrollment 75
Est. completion date October 25, 2022
Est. primary completion date October 25, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 6 Months to 24 Months
Eligibility Inclusion Criteria: - 75 healthy infants aged 6-24 months were included. Exclusion Criteria: - Having a physical/mental/neuromotor/psychological problem - Not between 6-24 months in the pandemic process - Presence of a diagnosed disease - Having a vision problem - Having a hearing problem

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Group1
75 healthy infants were included. Neuromotor development was evaluated with the Denver II Developmental Screening Test and Alberta Infant motor scale.

Locations

Country Name City State
Turkey Acibadem Altunizade Hospital Istanbul

Sponsors (1)

Lead Sponsor Collaborator
Istanbul University - Cerrahpasa (IUC)

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Denver II Developmental Screening Test It is a screening test used in children aged 0-6 years. The test is done in a short time like 5-15 minutes. The person who will administer the Denver II test; must be trained and certified. Standardized test materials are used. The test consists of 4 sections and 134 items. There are personal-social, language, fine motor and gross motor sections. The test result is classified as Normal - Abnormal - Suspicious. baseline
Primary Alberta infant motor scale It is used to observe gross motor functions and evaluate the effectiveness of the intervention in typically developing infants between 0-18 months. The duration of the test is 10 minutes and consists of 58 items. The child's spontaneous movements are evaluated in 4 different positions without touching the child. 1 point is taken for each item that can be done. A table containing the mean and standard deviation for each month is used. The test result is classified as Normal - Abnormal - Suspicious. baseline
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03548779 - North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 N/A
Completed NCT04313283 - Translating Peer-to-Peer Support Into a Clinical Setting N/A
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Completed NCT03599648 - The Pro-Parenting Study: Helping Parents Reduce Behavior Problems in Preschool Children With Developmental Delay N/A
Active, not recruiting NCT03625115 - The Opening Doors to Early Intervention Study N/A
Completed NCT02970565 - Family Nurture Intervention, A Group Model in Connecticut N/A
Recruiting NCT04026386 - A Center Based Early Intervention Program For Preschoolers With Developmental Disorders N/A
Completed NCT03561168 - Review of Diagnostic Yield of MRI Brain Results in Children Under Age 3 Years
Recruiting NCT05885113 - Developmental Intervention for Hospitalized Newborns With Congenital Heart Disease N/A
Completed NCT04562038 - Implementation of Electronic Shared Decision-Making Support for Early Intervention N/A
Recruiting NCT03472807 - EXOme Rare Cancers in Children (EXOCARE) N/A
Active, not recruiting NCT05117827 - Pediatric Powered Wheelchair Standing Devices: An Exploratory Study N/A
Completed NCT05408351 - The Indonesian Version of Ages and Stages Questionnaire III Accuracy Compared to Bayley Scales of Infant Development III
Recruiting NCT05803252 - Videoconferencing-based Focused Acceptance and Commitment Therapy for Parents of SHCN Children N/A
Terminated NCT04398667 - European Non-interventional Study on Refractory Epilepsy With Developmental Delay
Not yet recruiting NCT06412653 - Prospective Pilot Trial to Address Feasibility and Safety of Oral Zinc in GNAO1 Associated Disorders Phase 2
Completed NCT04048720 - Norwalk Feasibility Study N/A
Not yet recruiting NCT03209453 - Effects of Family Work Shop for Children With Developmental Delays: a Randomized Trial N/A
Recruiting NCT05751525 - Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes (iDEND) Syndrome
Completed NCT03908268 - Children's Learning Centers Group FNI N/A